Skip to main content

Table 1 Characteristic changes of HFMD cases in 2013–2015, 2017–2019 and 2020–2022 of chengdu area

From: Molecular epidemiology and clinical characteristics of enteroviruses associated HFMD in Chengdu, China, 2013–2022

Characteristics

2013–2015

(N = 12,599)

2017–2019

(N = 8216)

2020–2022

(N = 3348)

P1 value

P2 value

Gender, n(%)

   

0.019a

0.334a

 Male

7317 (58.08)

4636 (56.43)

1922 (57.41)

  

 Female

5282 (41.92)

3580 (43.57)

1426 (42.59)

  

 Male Female

1.39

1.29

1.34

  

Median age, month (P25, P75)

26 (16–36)

25 (15–36)

25 (16–36)

0.331b

 < 0.001b

Age group,month, n (%)

   

 < 0.001a

 < 0.001a

 0–11

1335 (10.60)

1069 (13.01)

372 (11.11)

  

 12–23

4329 (34.36)

2868 (34.91)

1170 (34.95)

  

 24–47

5658 (44.91)

3105 (37.79)

1201 (35.87)

  

 > 48

1277 (10.14)

1174 (14.29)

605 (18.07)

  

Serotypes, n (%)

   

 < 0.001a

 < 0.001a

 EV-A71

1713 (13.60)

150 (1.83)

0 (0)

  

 CV.A16

1759 (13.96)

891 (10.84)

152 (4.54)

  

 Other enterovirus 1

9127 (72.44)

7175 (87.33)

3196 (95.45)

  

 CV-A6

1687 (50.39)

  

 CV-A10

362 (10.81)

  

 Other enterovirus 2

1147 (34.26)

  

In/outpatient, n (%)

   

 < 0.001a

0.020a

 Inpatient

1061 (8.42)

390 (6.73)

126 (3.76)

  

 Outpatient

11,538 (91.58)

7826 (93.27)

3222 (96.24)

  
  1. Other enterovirus l: No-EV-A71 andNo-CV-A16 enterovirus; Other enterovirus 2: No-EV-A71; No-CV-A16; N0-CV-A6 and No-CV-AlO entennirus; P1 value: the data in 2017–2019 compared with 2013–2015; P2 value: the data in 2020–2022 compared with 2017–2019; ameans Chi-square test was used for statistical analysis; bmeans Mann Whitney U test was used for statistical analysis:"–" indicates that no data of CV-A6 and CV-A10 were collected during 2013–2019